Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication.
Name:
Chhatwal et al_final.pdf
Size:
844.5Kb
Format:
PDF
Description:
Open Access publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Chhatwal, PatrickBankwitz, Dorothea
Gentzsch, Juliane
Frentzen, Anne
Schult, Philipp
Lohmann, Volker
Pietschmann, Thomas
Issue Date
2012
Metadata
Show full item recordAbstract
Hepatitis C virus (HCV) patients with high serum levels of bile acids (BAs) respond poorly to IFN therapy. BAs have been shown to increase RNA-replication of genotype 1 but not genotype 2a replicons. Since BAs modulate lipid metabolism including lipoprotein secretion and as HCV depends on lipids and lipoproteins during RNA-replication, virus production and cell entry, BAs may affect multiple steps of the HCV life cycle. Therefore, we analyzed the influence of BAs on individual steps of virus replication.Citation
Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication. 2012, 7 (4):e36029 PLoS ONEAffiliation
Department of Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany.Journal
PloS onePubMed ID
22558311Type
ArticleLanguage
enISSN
1932-6203ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0036029
Scopus Count
The following license files are associated with this item:
Related articles
- Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.
- Authors: Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, André P
- Issue date: 2008 Feb
- Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
- Authors: Wose Kinge CN, Espiritu C, Prabdial-Sing N, Sithebe NP, Saeed M, Rice CM
- Issue date: 2014 Sep
- Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
- Authors: Robinson M, Yang H, Sun SC, Peng B, Tian Y, Pagratis N, Greenstein AE, Delaney WE 4th
- Issue date: 2010 Aug
- In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
- Authors: Yu M, Corsa AC, Xu S, Peng B, Gong R, Lee YJ, Chan K, Mo H, Delaney W 4th, Cheng G
- Issue date: 2013 Nov
- Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
- Authors: Gu B, Gates AT, Isken O, Behrens SE, Sarisky RT
- Issue date: 2003 May